Finally, a particular subform of MDD is associated with hyperaldosteronism, and a possible role for drugs that interfere with the renin–angiotensin–aldosterone system (RAAS) seems to be an underused option that could provide a good outcome in the treatment of MDD, especially that associated with high aldosterone levels [128]. This evidence concerns the gene REN and major depressive disorder.